André Lieber

12.9k total citations · 1 hit paper
209 papers, 10.4k citations indexed

About

André Lieber is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, André Lieber has authored 209 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Genetics, 135 papers in Molecular Biology and 74 papers in Oncology. Recurrent topics in André Lieber's work include Virus-based gene therapy research (146 papers), Viral Infectious Diseases and Gene Expression in Insects (60 papers) and CAR-T cell therapy research (60 papers). André Lieber is often cited by papers focused on Virus-based gene therapy research (146 papers), Viral Infectious Diseases and Gene Expression in Insects (60 papers) and CAR-T cell therapy research (60 papers). André Lieber collaborates with scholars based in United States, Germany and France. André Lieber's co-authors include Dmitry M. Shayakhmetov, Anuj Gaggar, Mark A. Kay, Shaoheng Ni, Zong-Yi Li, Robert Strauss, Dirk S. Steinwaerder, Thalia Papayannopoulou, Hongjie Wang and Mike Strauss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

André Lieber

204 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD46 is a cellular receptor for group B adenoviruses

2003 648 citations André Lieber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Lieber United States	57	6.9k	6.6k	3.6k	1.8k	1.5k	209	10.4k
Roland W. Herzog United States	60	8.5k 1.2×	8.1k 1.2×	3.9k 1.1×	1.3k 0.7×	1.3k 0.9×	218	12.9k
Richard G. Vile United States	67	8.2k 1.2×	6.2k 0.9×	6.0k 1.6×	1.9k 1.1×	3.9k 2.6×	278	13.7k
Thomas J. Wickham United States	47	6.3k 0.9×	5.9k 0.9×	3.1k 0.9×	1.4k 0.8×	738 0.5×	95	9.0k
Glen R. Nemerow United States	59	6.8k 1.0×	6.6k 1.0×	3.5k 0.9×	2.6k 1.5×	2.4k 1.6×	137	12.4k
Alan Melcher United Kingdom	60	5.6k 0.8×	3.7k 0.6×	5.5k 1.5×	1.7k 1.0×	3.6k 2.4×	245	10.5k
Donald B. Kohn United States	69	7.8k 1.1×	9.8k 1.5×	3.6k 1.0×	1.1k 0.6×	3.1k 2.0×	361	16.0k
Michael C. Holmes United States	45	5.3k 0.8×	12.5k 1.9×	2.4k 0.7×	608 0.3×	1.0k 0.7×	104	14.7k
Hardev Pandha United Kingdom	50	4.0k 0.6×	3.4k 0.5×	3.6k 1.0×	1.2k 0.7×	1.8k 1.2×	223	7.8k
David H. Kirn United States	64	12.1k 1.8×	8.6k 1.3×	8.9k 2.4×	1.6k 0.9×	1.8k 1.2×	144	15.8k
Ramón Alemany Spain	51	6.2k 0.9×	5.0k 0.8×	4.7k 1.3×	828 0.5×	893 0.6×	162	8.3k

Countries citing papers authored by André Lieber

Since Specialization

Citations

This map shows the geographic impact of André Lieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Lieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Lieber more than expected).

Fields of papers citing papers by André Lieber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Lieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Lieber. The network helps show where André Lieber may publish in the future.

Co-authorship network of co-authors of André Lieber

This figure shows the co-authorship network connecting the top 25 collaborators of André Lieber. A scholar is included among the top collaborators of André Lieber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Lieber. André Lieber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Chang, Benjamin J. Mallory, Elliott Swanson, et al.. (2024). Resolving the chromatin impact of mosaic variants with targeted Fiber-seq. Genome Research. 34(12). 2269–2278. 4 indexed citations

Li, Chang, Aphrodite Georgakopoulou, Gregory A. Newby, et al.. (2023). In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. Blood. 141(17). 2085–2099. 51 indexed citations

Li, Chang, Aphrodite Georgakopoulou, Gregory A. Newby, et al.. (2022). In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. JCI Insight. 7(19). 24 indexed citations

Vernal, Sebastián, et al.. (2022). Autoantibodies against desmoglein 2 are not pathogenic in pemphigus. Anais Brasileiros de Dermatologia. 97(2). 145–156. 2 indexed citations

Wang, Hongjie, Franziska Jönsson, Malik Aydin, et al.. (2022). Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of Oncolytic Approaches and Gene Therapy. Viruses. 14(8). 1835–1835. 5 indexed citations

Cannon, Paula M., Aravind Asokan, Agnieszka Czechowicz, et al.. (2021). Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development. Human Gene Therapy. 32(1-2). 31–42. 17 indexed citations

Psatha, Nikoletta, Aphrodite Georgakopoulou, Chang Li, et al.. (2021). Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 138(17). 1540–1553. 29 indexed citations

Li, Chang, et al.. (2019). Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models. Cancer Research. 80(3). 549–560. 16 indexed citations

Lieber, André, Hongjie Wang, Nikoletta Psatha, et al.. (2017). In Vivo HSC Transduction and Selection Results in Long-Term, High-Level Expression of Human Gamma Globin in Peripheral Blood Erythrocytes of Mice. Blood. 130. 4616–4616. 1 indexed citations

10.

Richter, Maximilian, Kamola Saydaminova, Roma Yumul, et al.. (2016). In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood. 128(18). 2206–2217. 84 indexed citations

11.

Beyer, Ines, Hua Cao, Jonas Persson, et al.. (2012). Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs. Clinical Cancer Research. 18(12). 3340–3351. 53 indexed citations

12.

Beyer, Ines, Ruan van Rensburg, Robert Strauss, et al.. (2011). Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer. Cancer Research. 71(22). 7080–7090. 69 indexed citations

13.

Alba, Richard, Angela C. Bradshaw, Lynda Coughlan, et al.. (2010). Biodistribution and retargeting of FX-binding ablated Ad5 vectors. UCL Discovery (University College London). 1 indexed citations

14.

Chen, Bing‐Mae, Pei‐Chun Wu, Tian‐Lu Cheng, et al.. (2010). Cutting Edge: Mechanical Forces Acting on T Cells Immobilized via the TCR Complex Can Trigger TCR Signaling. The Journal of Immunology. 184(11). 5959–5963. 170 indexed citations

15.

Strauss, Robert, Pavel Sova, Ying Liu, et al.. (2009). Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses. Cancer Research. 69(12). 5115–5125. 57 indexed citations

16.

Benlahrech, Adel, Julian D. Harris, Andrea Meiser, et al.. (2009). Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proceedings of the National Academy of Sciences. 106(47). 19940–19945. 119 indexed citations

17.

Tuve, Sebastian, Bing-Mae Chen, Ying Liu, et al.. (2007). Combination of Tumor Site–Located CTL-Associated Antigen-4 Blockade and Systemic Regulatory T-Cell Depletion Induces Tumor-Destructive Immune Responses. Cancer Research. 67(12). 5929–5939. 75 indexed citations

18.

Bernt, Kathrin M., et al.. (2005). Assessment of a Combined, Adenovirus-Mediated Oncolytic and Immunostimulatory Tumor Therapy. Cancer Research. 65(10). 4343–4352. 43 indexed citations

19.

Lieber, André, Marie-Jeanne T.F.D. Vrancken Peeters, Allen M. Gown, James D. Perkins, & Mark A. Kay. (1995). A Modified Urokinase Plasminogen Activator Induces Liver Regeneration Without Bleeding. Human Gene Therapy. 6(8). 1029–1037. 42 indexed citations

20.

Lieber, André, Volker Sandig, & Mike Strauss. (1993). A mutant T7 phage promoter is specifically transcribed by T7‐RNA polymerase in mammalian cells. European Journal of Biochemistry. 217(1). 387–394. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact